Cholangiopancreatoscopy and endoscopic ultrasound for indeterminate pancreaticobiliary pathology

Abdul H. Khan, Greg L. Austin, Norio Fukami, Amrita Sethi, Brian C. Brauer, Raj J. Shah

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Techniques to confirm suspected pancreaticobiliary (PB) malignancy when index sampling is non-diagnostic include cholangiopancreatoscopy (CP) and endoscopic ultrasound (EUS). However, comparative data are lacking. Aim: The purpose of this study was to compare the yield of EUS and CP for the diagnosis of PB pathology. Methods: Consecutive patients with indeterminate PB pathology who underwent both CP and EUS within 3 months of each other were retrospectively identified. For CP, tissue sampling included biopsy under direct inspection (cholangioscopy-directed biopsy), biopsy following CP with fluoroscopic guidance (cholangioscopy-assisted biopsy), or brush cytology. For EUS-FNA, lesions included ductal strictures or hypoechoic masses. A comparison of operating characteristics between CP and EUS utilizing tissue confirmation or 12-month clinical course consistent with either benign or malignant disease was performed. Results: Between February 2000 and June 2007, 66 (33 males, 33 females, median age 64.5) patients with indeterminate PB pathology who had undergone both CP and EUS within 3 months of each other were included. Lesions amenable to sampling were noted in 59 CP and 50 EUS patients. On follow-up, 39 patients had neoplasia and 27 were benign. The sensitivity/specificity for the diagnosis of neoplasia for CP and EUS was 48.7/96.3 % and 33.3/96.3 %, respectively (comparison of sensitivities, P = 0.183). The combined (CP and EUS) sensitivity/specificity was 66.7/96.3 % (P = 0.0064 and P = 0.0001 comparing combined sensitivity vs. sensitivity of either CP alone or EUS alone, respectively). Conclusions: In patients who undergo both EUS and CP for indeterminate PB pathology, the combined yield of EUS and CP to detect neoplasia appears to be higher than either examination alone.

Original languageEnglish (US)
Pages (from-to)1110-1115
Number of pages6
JournalDigestive Diseases and Sciences
Volume58
Issue number4
DOIs
StatePublished - Apr 1 2013
Externally publishedYes

Fingerprint

Pathology
Biopsy
Neoplasms
Sensitivity and Specificity
Cell Biology
Pathologic Constriction

Keywords

  • Cholangiocarcinoma
  • Cholangioscopy
  • ERCP
  • EUS
  • Pancreatic cancer
  • Pancreatoscopy

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology

Cite this

Cholangiopancreatoscopy and endoscopic ultrasound for indeterminate pancreaticobiliary pathology. / Khan, Abdul H.; Austin, Greg L.; Fukami, Norio; Sethi, Amrita; Brauer, Brian C.; Shah, Raj J.

In: Digestive Diseases and Sciences, Vol. 58, No. 4, 01.04.2013, p. 1110-1115.

Research output: Contribution to journalArticle

Khan, Abdul H. ; Austin, Greg L. ; Fukami, Norio ; Sethi, Amrita ; Brauer, Brian C. ; Shah, Raj J. / Cholangiopancreatoscopy and endoscopic ultrasound for indeterminate pancreaticobiliary pathology. In: Digestive Diseases and Sciences. 2013 ; Vol. 58, No. 4. pp. 1110-1115.
@article{4e819231f13c441499db86d558380b52,
title = "Cholangiopancreatoscopy and endoscopic ultrasound for indeterminate pancreaticobiliary pathology",
abstract = "Background: Techniques to confirm suspected pancreaticobiliary (PB) malignancy when index sampling is non-diagnostic include cholangiopancreatoscopy (CP) and endoscopic ultrasound (EUS). However, comparative data are lacking. Aim: The purpose of this study was to compare the yield of EUS and CP for the diagnosis of PB pathology. Methods: Consecutive patients with indeterminate PB pathology who underwent both CP and EUS within 3 months of each other were retrospectively identified. For CP, tissue sampling included biopsy under direct inspection (cholangioscopy-directed biopsy), biopsy following CP with fluoroscopic guidance (cholangioscopy-assisted biopsy), or brush cytology. For EUS-FNA, lesions included ductal strictures or hypoechoic masses. A comparison of operating characteristics between CP and EUS utilizing tissue confirmation or 12-month clinical course consistent with either benign or malignant disease was performed. Results: Between February 2000 and June 2007, 66 (33 males, 33 females, median age 64.5) patients with indeterminate PB pathology who had undergone both CP and EUS within 3 months of each other were included. Lesions amenable to sampling were noted in 59 CP and 50 EUS patients. On follow-up, 39 patients had neoplasia and 27 were benign. The sensitivity/specificity for the diagnosis of neoplasia for CP and EUS was 48.7/96.3 {\%} and 33.3/96.3 {\%}, respectively (comparison of sensitivities, P = 0.183). The combined (CP and EUS) sensitivity/specificity was 66.7/96.3 {\%} (P = 0.0064 and P = 0.0001 comparing combined sensitivity vs. sensitivity of either CP alone or EUS alone, respectively). Conclusions: In patients who undergo both EUS and CP for indeterminate PB pathology, the combined yield of EUS and CP to detect neoplasia appears to be higher than either examination alone.",
keywords = "Cholangiocarcinoma, Cholangioscopy, ERCP, EUS, Pancreatic cancer, Pancreatoscopy",
author = "Khan, {Abdul H.} and Austin, {Greg L.} and Norio Fukami and Amrita Sethi and Brauer, {Brian C.} and Shah, {Raj J.}",
year = "2013",
month = "4",
day = "1",
doi = "10.1007/s10620-012-2471-2",
language = "English (US)",
volume = "58",
pages = "1110--1115",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Cholangiopancreatoscopy and endoscopic ultrasound for indeterminate pancreaticobiliary pathology

AU - Khan, Abdul H.

AU - Austin, Greg L.

AU - Fukami, Norio

AU - Sethi, Amrita

AU - Brauer, Brian C.

AU - Shah, Raj J.

PY - 2013/4/1

Y1 - 2013/4/1

N2 - Background: Techniques to confirm suspected pancreaticobiliary (PB) malignancy when index sampling is non-diagnostic include cholangiopancreatoscopy (CP) and endoscopic ultrasound (EUS). However, comparative data are lacking. Aim: The purpose of this study was to compare the yield of EUS and CP for the diagnosis of PB pathology. Methods: Consecutive patients with indeterminate PB pathology who underwent both CP and EUS within 3 months of each other were retrospectively identified. For CP, tissue sampling included biopsy under direct inspection (cholangioscopy-directed biopsy), biopsy following CP with fluoroscopic guidance (cholangioscopy-assisted biopsy), or brush cytology. For EUS-FNA, lesions included ductal strictures or hypoechoic masses. A comparison of operating characteristics between CP and EUS utilizing tissue confirmation or 12-month clinical course consistent with either benign or malignant disease was performed. Results: Between February 2000 and June 2007, 66 (33 males, 33 females, median age 64.5) patients with indeterminate PB pathology who had undergone both CP and EUS within 3 months of each other were included. Lesions amenable to sampling were noted in 59 CP and 50 EUS patients. On follow-up, 39 patients had neoplasia and 27 were benign. The sensitivity/specificity for the diagnosis of neoplasia for CP and EUS was 48.7/96.3 % and 33.3/96.3 %, respectively (comparison of sensitivities, P = 0.183). The combined (CP and EUS) sensitivity/specificity was 66.7/96.3 % (P = 0.0064 and P = 0.0001 comparing combined sensitivity vs. sensitivity of either CP alone or EUS alone, respectively). Conclusions: In patients who undergo both EUS and CP for indeterminate PB pathology, the combined yield of EUS and CP to detect neoplasia appears to be higher than either examination alone.

AB - Background: Techniques to confirm suspected pancreaticobiliary (PB) malignancy when index sampling is non-diagnostic include cholangiopancreatoscopy (CP) and endoscopic ultrasound (EUS). However, comparative data are lacking. Aim: The purpose of this study was to compare the yield of EUS and CP for the diagnosis of PB pathology. Methods: Consecutive patients with indeterminate PB pathology who underwent both CP and EUS within 3 months of each other were retrospectively identified. For CP, tissue sampling included biopsy under direct inspection (cholangioscopy-directed biopsy), biopsy following CP with fluoroscopic guidance (cholangioscopy-assisted biopsy), or brush cytology. For EUS-FNA, lesions included ductal strictures or hypoechoic masses. A comparison of operating characteristics between CP and EUS utilizing tissue confirmation or 12-month clinical course consistent with either benign or malignant disease was performed. Results: Between February 2000 and June 2007, 66 (33 males, 33 females, median age 64.5) patients with indeterminate PB pathology who had undergone both CP and EUS within 3 months of each other were included. Lesions amenable to sampling were noted in 59 CP and 50 EUS patients. On follow-up, 39 patients had neoplasia and 27 were benign. The sensitivity/specificity for the diagnosis of neoplasia for CP and EUS was 48.7/96.3 % and 33.3/96.3 %, respectively (comparison of sensitivities, P = 0.183). The combined (CP and EUS) sensitivity/specificity was 66.7/96.3 % (P = 0.0064 and P = 0.0001 comparing combined sensitivity vs. sensitivity of either CP alone or EUS alone, respectively). Conclusions: In patients who undergo both EUS and CP for indeterminate PB pathology, the combined yield of EUS and CP to detect neoplasia appears to be higher than either examination alone.

KW - Cholangiocarcinoma

KW - Cholangioscopy

KW - ERCP

KW - EUS

KW - Pancreatic cancer

KW - Pancreatoscopy

UR - http://www.scopus.com/inward/record.url?scp=84876676372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876676372&partnerID=8YFLogxK

U2 - 10.1007/s10620-012-2471-2

DO - 10.1007/s10620-012-2471-2

M3 - Article

C2 - 23161267

AN - SCOPUS:84876676372

VL - 58

SP - 1110

EP - 1115

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 4

ER -